脂多糖诱导的神经炎症通过小胶质细胞衍生的白细胞介素 1β对脑组织的直接作用引起突触前破坏。
Lipopolysaccharide-induced neuroinflammation induces presynaptic disruption through a direct action on brain tissue involving microglia-derived interleukin 1 beta.
机构信息
John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, E.D Adrian Building, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK.
Signalling Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.
出版信息
J Neuroinflammation. 2019 May 18;16(1):106. doi: 10.1186/s12974-019-1490-8.
BACKGROUND
Systemic inflammation has been linked to synapse loss and cognitive decline in human patients and animal models. A role for microglial release of pro-inflammatory cytokines has been proposed based on in vivo and primary culture studies. However, mechanisms are hard to study in vivo as specific microglial ablation is challenging and the extracellular fluid cannot be sampled without invasive methods. Primary cultures have different limitations as the intricate multicellular architecture in the brain is not fully reproduced. It is essential to confirm proposed brain-specific mechanisms of inflammatory synapse loss directly in brain tissue. Organotypic hippocampal slice cultures (OHSCs) retain much of the in vivo neuronal architecture, synaptic connections and diversity of cell types whilst providing convenient access to manipulate and sample the culture medium and observe cellular reactions.
METHODS
OHSCs were generated from P6-P9 C57BL/6 mice. Inflammation was induced via addition of lipopolysaccharide (LPS), and cultures were analysed for changes in synaptic proteins, gene expression and protein secretion. Microglia were selectively depleted using clodronate, and the effect of IL1β was assessed using a specific neutralising monoclonal antibody.
RESULTS
LPS treatment induced loss of the presynaptic protein synaptophysin without altering PSD95 or Aβ protein levels. Depletion of microglia prior to LPS application prevented the loss of synaptophysin, whilst microglia depletion after the inflammatory insult was partially effective, although less so than pre-emptive treatment, indicating a time-critical window in which microglia can induce synaptic damage. IL1β protein and mRNA were increased after LPS addition, with these effects also prevented by microglia depletion. Direct application of IL1β to OHSCs resulted in synaptophysin loss whilst pre-treatment with IL1β neutralising antibody prior to LPS addition prevented a significant loss of synaptophysin but may also impact basal synaptic levels.
CONCLUSIONS
The loss of synaptophysin in this system confirms LPS can act directly within brain tissue to disrupt synapses, and we show that microglia are the relevant cellular target when all major CNS cell types are present. By overcoming limitations of primary culture and in vivo work, our study strengthens the evidence for a key role of microglia-derived IL1β in synaptic dysfunction after inflammatory insult.
背景
系统性炎症与人类患者和动物模型中的突触损失和认知能力下降有关。基于体内和原代培养研究,提出了小胶质细胞释放促炎细胞因子的作用。然而,由于特定的小胶质细胞消融具有挑战性,并且没有侵入性方法就无法从细胞外液中取样,因此很难在体内研究机制。原代培养具有不同的局限性,因为大脑中复杂的多细胞结构不能完全复制。在脑组织中直接确认炎症性突触损失的拟议脑特异性机制至关重要。器官型海马切片培养物 (OHSCs) 保留了大量体内神经元结构、突触连接和细胞类型的多样性,同时提供了方便的途径来操纵和取样培养基并观察细胞反应。
方法
从 P6-P9 C57BL/6 小鼠中生成 OHSCs。通过添加脂多糖 (LPS) 诱导炎症,并分析突触蛋白、基因表达和蛋白质分泌的变化。使用氯膦酸盐选择性耗尽小胶质细胞,并使用特异性中和单克隆抗体评估 IL1β 的作用。
结果
LPS 处理诱导突触前蛋白突触小泡蛋白丢失,而不改变 PSD95 或 Aβ 蛋白水平。在 LPS 应用前耗尽小胶质细胞可防止突触小泡蛋白丢失,而炎症损伤后的小胶质细胞耗竭则部分有效,尽管不如抢先治疗有效,表明小胶质细胞可以诱导突触损伤的时间关键窗口。LPS 加药后 IL1β 蛋白和 mRNA 增加,小胶质细胞耗竭也可防止这些作用。直接向 OHSCs 施加 IL1β 导致突触小泡蛋白丢失,而在 LPS 加药前用 IL1β 中和抗体预处理可防止突触小泡蛋白明显丢失,但也可能影响基础突触水平。
结论
在这个系统中,突触小泡蛋白的丢失证实 LPS 可以直接在脑组织内作用以破坏突触,并且我们表明,当所有主要中枢神经系统细胞类型都存在时,小胶质细胞是相关的细胞靶标。通过克服原代培养和体内工作的局限性,我们的研究加强了小胶质细胞衍生的 IL1β 在炎症损伤后突触功能障碍中的关键作用的证据。